| Jul 2 |
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
|
| Jun 30 |
Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts?
|
| Jun 21 |
Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children’s Bone Health (ICCBH)
|
| May 30 |
Inozyme Pharma to Present at the Jefferies Global Healthcare Conference
|
| May 23 |
Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences
|
